All Products
Detailed Product Information
Colicare 10
Ulcerative Colitis (UC) is a chronic condition which primarily affects the inner lining of the large intestine and rectum. Over 1 million are affected by this disease and is more common in men than women.
Most clinical research documents recommend a minimum of 8 weeks of use is needed for maximum effectiveness.
Crohncare 10
Crohn’s Disease is a chronic inflammatory process which can involve the entire intestinal tract which penetrates all layers of the gut wall. It is in the same family of disease called Irritable Bowel Disease- separate and not to be confused with Irritable Bowel Syndrome- which also includes Ulcerative Colitis. Over 1 million people in the US suffer from Crohn’s Disease. It is most common in women. Crohn’s disease is exacerbated by “leaky gut syndrome” where the epithelial cells lose their tight binding and allow offensive bacteria and other pro-inflammatory chemicals to get into the lining and blood and sets up a difficult and painful long term effect.
Most clinical research documents recommend a minimum of 8 weeks of use is needed for maximum effectiveness.
Fibrocare 10
Fibromyalgia is characterized by a chronic increased sensitivity to pain through its receptors and manifests in chronic fatigue, pain and cognitive disorders such as concentration and sleep deprivation. Often, Fibromyalgia has a gradual onset which can be related to other rheumatology conditions such as osteoarthritis, lupus and similar family history.
Most clinical research documents recommend a minimum of 8 weeks of use is needed for maximum effectiveness.
IBSyncare 10
Irritable Bowel Syndrome (IBS) is a set of dysfunctions in the gut which manifests in several ways including intestinal spasms, constipation, pain and diarrhea. Frequently, precipitating factors to acute illness is triggered by stress, hormones, environment and gut microbiome. IBS is chronic and occurs in 10-15% of the US population - more commonly in women and mostly starting under the age of 50.
Most clinical research documents recommend a minimum of 8 weeks of use is needed for maximum effectiveness.